Company Global Pharmatech, Inc.

Equities

GBLP

US37945N1090

Pharmaceuticals

Market Closed - OTC Markets 15:07:56 2024-02-27 EST 5-day change 1st Jan Change
0.15 USD -37.50% Intraday chart for Global Pharmatech, Inc. -.--% -37.50%

Business Summary

Global Pharmatech, Inc., formerly Global Pharmatech Pvt. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. It offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The Company registers products in various markets around the world.

Number of employees: 217

Sales per Business

USD in Million2022Weight2023Weight Delta
Proprietary Drugs
100.0 %
0 100.0 % 0 100.0 % +13.30%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
0 100.0 % 0 100.0 % +13.30%

Managers

Managers TitleAgeSince
Director/Board Member - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,614,085 391,259,667 ( 1,656.89 %) 0 1,656.89 %

Company contact information

Global Pharmatech, Inc.

7/F, Fa Yuen Commercial Building Fa Yuen Street, Flat 705

999077, Hong Kong

+

address Global Pharmatech, Inc.(GBLP)
  1. Stock Market
  2. Equities
  3. GBLP Stock
  4. Company Global Pharmatech, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW